ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders
Stefania Demuro, Conall Sauvey, Shailesh Tripathi, Rita Maria Concetta Di Martino, Da Shi, Jose A. Ortega, Debora Russo, Beatrice Balboni, Barbara Giabbai, Paola Storici, Stefania Girotto, Ruben Abagyan, Andrea Cavalli
Topics & Concepts
FYNDYRK1AChemistryPhosphorylationHyperphosphorylationNeuroscienceKinomeDrug discoveryNeurodegenerationTau proteinKinaseAlzheimer's diseaseCell biologyBiochemistryBiologyProto-oncogene tyrosine-protein kinase SrcDiseaseMedicineInternal medicineAlzheimer's disease research and treatmentsCellular transport and secretionProtein Kinase Regulation and GTPase Signaling